FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 265 of 265

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
VTGN Nasdaq Vistagen Therapeutics, Inc. 2830
VTVT Nasdaq vTv Therapeutics Inc. 2830
VTYX Nasdaq Ventyx Biosciences, Inc. 2830
WALD Nasdaq Waldencast plc 2830
XAIR Nasdaq Beyond Air, Inc. 2830
XERS Nasdaq Xeris Biopharma Holdings, Inc. 2830
XFOR Nasdaq X4 Pharmaceuticals, Inc. 2830
XNCR Nasdaq Xencor, Inc. 2830
XTLB Nasdaq XTL Biopharmaceuticals Ltd. 2830
YCBD NYSE American cbdMD, Inc. 2830
ZLAB Nasdaq Zai Lab Limited 2830
ZTS New York Zoetis Inc. 2830
ZURA Nasdaq Zura Bio Limited 2830
ZVRA Nasdaq Zevra Therapeutics, Inc. 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 265 of 265